Skip to main content
logo
HomeStocksADVENZYMES

A

Advanced Enzyme Tech

₹ 280.30

-4.00 (-1.41%)loss
as on 06 Nov 2026 at 03:29 PM
views8.3K
portfolio567
analyst100% Buy
Overview
Pros & Cons
News
History
Fundamentals
Investment Returns
Technicals
Financials
Balance Sheet
Cash Flow
Corporate Actions
Peers

Advanced Enzyme Tech Share Price Today

Advanced Enzyme Tech (ADVENZYMES) share price is trading at ₹280.30 on the NSE as of November 6, 2026 at 03:29 PM, down by 1.41% from its previous close of ₹284.30. In todays trading session ADVENZYMES reached a high of 284.70 and low of 278.25. The average traded price for today is 280.77. The 50 DMA stands at 280.59 and 200 DMA is at 308.64. Looking at intraday trend, the stock is in Downtrend.

Stock Overview

  • Symbol : ADVENZYMES
  • Open : ₹284.30
  • Previous Close : ₹284.30
  • Day's Range : ₹278.25 – ₹284.70
  • 52-Week Range : ₹246.80 – ₹419.00
Trading Charts Logo

Get 20+ Chart Types, 180+ Indicators, 80+ Drawing Tools & Create Custom Indicators for FREE.

Go to Charts

ADVENZYMES Stock Performance

Markets Today

High

284.70

Low

278.25

Open at

284.30

Prev Close

284.30

Volumes

2,36,638

Avg Price

280.77

Lower Circuit

224.25

Upper Circuit

336.35

Last Traded Details

Quantity

481

Time

15:29:59

Price Movement

278.25284.70
0.74%Loss
down side
up side
1.55%Profit

Historical Performance

3 M High

337.85

3 M Low

246.80

1 Yr High

419.00

1 Yr Low

246.80

3 Yr High

571.00

3 Yr Low

246.80

5 Yr High

571.00

5 Yr Low

225.00

1-Year Performance

246.80419.00
13.57%Loss
down side
up side
33.10%Profit

ADVENZYMES Pros and Cons

byfuzz AI

Consolidated revenue grew from ₹1,845 Cr to ₹2,145 Cr over five quarters, reaching a new high in Q2 FY26

EBITDA margin recovered from 27% in Q1 FY26 to 34% in Q2 FY26, signaling improved operational efficiency

India revenue expanded from ₹887 Cr to ₹1,110 Cr, now contributing 52% of total sales

Human Nutrition revenue rebounded from ₹962 Cr to ₹1,285 Cr, stabilizing as the largest segment at 60% contribution

Specialized Manufacturing revenue rose from ₹185 Cr to ₹231 Cr, gaining share to 11% of total revenue

Market capitalization fell from ₹36,440 Cr to ₹31,689 Cr, remaining below the Q2 FY25 peak despite profit growth

Finance costs doubled from ₹6 Cr to ₹12 Cr in Q2 FY26, adding pressure on net profit margins

Europe revenue fluctuated from ₹116 Cr to ₹104 Cr, showing volatility compared to steady growth in other regions

fuzz Insights
Positive

Industrial segment bounced back. Profits followed suit.

Positive

Small segment grew steadily. Contribution stayed flat.

Neutral

Factory profits swung wildly. Reported profits stayed flat.

Neutral

Sales hit record highs. Costs rose just as fast.

Negative

Biggest segment stumbled. Company profits dipped with it.

Negative

Borrowing costs doubled. Profits took a small hit.

ADVENZYMES Analyst Rating

Buy

Analysts have suggested that investors can Buy this Stock

- By Refinitiv from 2 analysts

Buy

100%

Hold

0%

Sell

0%

Get forecast for Price, ROA & ROE based on analyst ratings.

Get Forecast

ADVENZYMES Share Price History

ADVENZYMES Fundamentals

Company Valuation

Market Cap (₹ Cr.)

3,116

PE Ratio

17.90

PB Ratio

1.91

Dividend Yield

1.88%

ROE

10.31%

ROCE

13.58%

Book Value (₹)

148.70

Face Value (₹)

2.00

Analyse ADVENZYMES with 12+ custom fundamentals and financial ratios.

Analyse Now

Share Holding Pattern

Held BySep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Promoters
43.07%43.04%43.26%43.24%43.56%
Domestic Institutional Investors (DII)
6.41%5.51%5.41%4.78%1.89%
Foreign Institutional Investors (FII)
25.41%25.86%25.49%26.71%26.65%
Public Investors
16.95%17.44%17.57%16.94%18.65%
Government
0.00%0.00%0.00%0.00%0.00%

Promoters

Domestic Institutional Investors (DII)

Foreign Institutional Investors (FII)

Public Investors

Government

Advanced Enzyme Tech Return Calculator

Current value of ₹1,00,000 invested 5 years ago, as on today

₹ 0

Loss

₹ 1,00,000 (21.93%)

Note: Past profits do not guarantee future returns.

ADVENZYMES Investment Returns

1 Week

1 Month

3 Months

6 Months

9 Months

Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.

ADVENZYMES Technicals

Moving Averages

PeriodSimpleSignal
5-SMA276.39Bullish
10-SMA266.70Bullish
20-SMA265.55Bullish
50-SMA280.59Bullish
100-SMA302.67Bearish
200-SMA308.64Bearish

Technical Indicators

IndicatorValueAction
RSI(14)59.85Neutral
ATR(14)10.52Less Volatile
STOCH(9,6)77.78Neutral
STOCH RSI(14)91.15Overbought
MACD(12,26)3.88Bullish
ADX(14)29.50Strong Trend

Summary of Technical Indicators for ADVENZYMES

Margin on ADVENZYMES

Order TypeMargin to PayLeverageQuantityTrade ValueMargin AmountActions

*Calculated on NSE. Applicable on all exchanges. Margins are subject to change from time to time or may be withdrawn under volatile market conditions. Intraday Orders are square-off automatically at 03:19 pm on NSE / BSE or on hitting 80% of margin utilisation (whichever earlier).

ADVENZYMES Financials Summary

View By:
Revenue
EBITDA
Net Profit
EPS
Revenue

In Crores

Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
195192211203223

ADVENZYMES Financials

View by

Income Statement

In Cr

Yearly StatementMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
536566661670781
Expenses328384419443517
208182241228264
Operating Profit201156205194229
Operating Profit Margin %38%29%33%31%31%
Other Income626373335
Interest22343
Depreciation3535353740
171140188187233
Tax %28%26%27%29%25%
Net Profit124104137134174
EPS119121215

Balance Sheet

In Cr

Yearly Balance SheetMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
1,2681,4221,5361,6211,839
Fixed Assets619649650679692
Current Assets6047228108801,044
Capital Work in Progress1522412251
Investments102360403480584
Other Assets531392442441512
1,2681,4221,5361,6211,839
Current Liabilities607810696107
Non Current Liabilities6760585649
1,1401,2841,3711,4691,683
Reserve & Surplus1,0661,2131,3021,3991,609
Share Capital2222222222
Minority Interest5249474851

Cash Flow

In Cr

Yearly Cash FlowMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Activities122140141143157
Investing Activities2-286-65-90-72
Financing Activities-49-26-59-73-70
Net Cash Flow75-17117-2015

Corporate Actions

DateCorporate ActionInformation
31st Oct 2026, Saturday
QUARTERLY RESULT ANNOUNCEMENTStock Result
Q2 FY 26-27 Results
info
8th Aug 2026, Saturday
QUARTERLY RESULT ANNOUNCEMENTStock Result
Q1 FY 26-27 Results
info
24th Jul 2026, Friday
DIVIDENDDividend
Final Dividend of ₹1.35/share
9th May 2026, Saturday
QUARTERLY RESULT ANNOUNCEMENTStock Result
Q4 FY 26-27 Results
info
31st Jan 2026, Saturday
QUARTERLY RESULT ANNOUNCEMENTStock Result
Q3 FY 25-26 Results
info

The above dates are ex-dates.

Check ADVENZYMES latest Company Filings, Investor Presentation & Conference Call details.

Read Now

ADVENZYMES Revenue Growth

All values are in Crores

Revenue

Profit

Loss

Financial YearRevenueRevenue GrowthNet ProfitProfit Growth
FY 2025-26516
25.01% profit
132
28.69% profit
FY 2024-25413
-2.68% Loss
102
-5.27% Loss
FY 2023-24424
32.04% profit
108
94.72% profit

ADVENZYMES Similar Stocks

Name
LTP
Change %
Volume
Market Cap (Cr.)arrow
PE Ratio
Industry PE
52W High
52W Low
1M Returns
3M Returns
1 Yr Returns
3 Yr Returns
5 Yr Returns
PB Ratio
Dividend Yield
ROE
ROCE
EPS
50 DMA
200 DMA
RSI
Sun Pharmaceutical

S

Sun Pharmaceutical

1,860.00

1.69%23,48,251₹ 4,46,27639.90-65.172,046.901,583.704.51%-4.12%10.06%63.00%-4.910.87%13.79%17.94%47.801,824.091,810.1466.96
Divis Laboratories

D

Divis Laboratories

10,320.50

1.78%8,86,474₹ 2,73,97792.1018.8310,159.005,647.5012.23%23.04%51.67%208.01%-16.080.30%15.32%18.96%96.759,404.937,401.5173.58
Torrent Pharmaceuticals

T

Torrent Pharmaceuticals

4,750.00

0.85%3,59,448₹ 1,80,67585.5031.645,250.003,532.60-0.46%-5.00%32.87%142.30%-9.770.81%12.16%9.06%63.924,783.254,528.5455.83
Laurus Labs

L

Laurus Labs

2,340.00

-0.21%14,45,453₹ 1,26,43395.10-65.172,441.90917.9518.70%27.52%138.01%542.33%-20.910.04%16.38%19.67%16.472,033.561,480.5169.39
Zydus Life Science

Z

Zydus Life Science

1,197.90

0.41%17,10,907₹ 1,19,49127.70-65.171,266.60835.505.17%6.85%23.28%104.82%-4.290.08%16.99%19.24%50.091,157.521,040.6456.37

FAQs on ADVENZYMES

Advanced Enzyme Tech share price as of today is ₹ 280.30 as on 06 Nov 2026 at 03:29 PM.
The 52W high of Advanced Enzyme Tech is ₹ 419.00 and 52W low is ₹ 246.80 as of 06 Nov 2026 at 15:29.
The past returns of Advanced Enzyme Tech share are -
  • Past 1 year: -10.72%
  • Past 3 years: -9.11%
  • Past 5 years: -21.93%
The PE and PB ratio of Advanced Enzyme Tech stands at 17.90 and 1.91 respectively as on 06 Nov 2026 at 15:29.
The EPS of Advanced Enzyme Tech is 4.33 for the quarter ended Sep 2026 and 15.08 for the financial year 2025-26.
The shareholding pattern of Advanced Enzyme Tech is as follows:
  • DIIs - 1.89%
  • FII - 26.65%
  • Promoters - 43.56%
  • Public Investors 18.65%
  • Goverenment - 0.00%
Yes, you can buy shares of Advanced Enzyme Tech online by opening Demat account with Dhan.
If you are a Dhan user already, you can buy Advanced Enzyme Tech stocks from Dhan Trading App or Web Trading Platform. If you are new to Dhan follow the below steps:
  1. Download the Dhan App to Open a Demat Account
  2. Navigate to the “Money Tab”
  3. Add money to your account
  4. Search for Advanced Enzyme Tech share
  5. Tap on “Buy”
With Dhan you can start a daily, weekly or monthly SIP in Advanced Enzyme Tech.
You can easily buy the shares of Advanced Enzyme Tech even after the markets are closed using the After Market Order feature on Dhan Trading App.


Explore  |  Sitemap

*All securities mentioned on this website are exemplary and not recommendatory.

*Current prices on the website are delayed by 15 mins, login to check live prices.

We are bullish on India, we are bullish on India's prospects to be one of the largest economies in the world. We believe that the stock market provides a unique opportunity for all of India's traders and investors to participate in the growth story of the country.

Yet, most investing & trading platforms in India have remained more or less the same over the past decade. Times have changed and retail traders and investors have become smarter about managing their trades and money. Modern traders & investors require an online trading platform that helps them keep up with the technological advancements of our time.

That's why we're building Dhan - to help you trade, to help you invest, and to help you participate in India's growth stock via the stock market with awesome features and an incredible experience.

©2021-2026 Raise Securities Private Limited (formerly Moneylicious Securities Private Limited). All rights reserved. CIN: U74999MH2012PTC433549 Raise Securities is part of Raise Financial Services and works closely with Raise Partners across services.

SEBI Stock Broker Registration No: INZ000006031 | Depository Participant (CDSL) ID: IN-DP-289-2016 | SEBI Research Analyst Registration No: INH000023357
Exchange Membership No. : NSE: 90133 | BSE: 6593 | MCX: 56320
Registered & Corporate Office: Unit No. 2201, 22nd Floor, Gold Medal Avenue, S.V. Road, Beside Patel Petrol Pump, Piramal Nagar, Goregaon West, Mumbai – 400104, Customer Care: 9987761000.


For any query / feedback / clarifications, email at help@dhan.co.

In case of grievances for any of the services rendered by Raise Securities Private Limited, please write to grievance@dhan.co (for NSE, BSE and MCX) or grievancedp@dhan.co (for Depository Participant). Please ensure that you carefully read the Risk Disclosure Document as prescribed by SEBI, our Terms of Use and Privacy Policy. Compliance Officer: Mr. Manish Garg and Mobile: 8655740961 Email: complianceofficer@dhan.co To lodge your complaints using SEBI SCORES, click here.


Disclaimer: All communications with the client via chat, phone, or email are for support purposes only. Any commitments or statements made by the agent (human or virtual) shall not be binding on the company.


DHAN is a brand owned by Raise Securities Private Limited. All DHAN clients are registered under Raise Securities Private Limited. Clients are advised to refer to our company as Raise Securities Private Limited when communicating with regulatory authorities.


Procedure to file a complaint on SEBI SCORES/SMART ODR Portal: Register on SCORES portal. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, E-mail ID. Benefits: Effective Communication, Speedy redressal of the grievances. You may refer the website https://scores.sebi.gov.in/ for more information. You may also download the SEBI Scores app to log a complaint Android: https://play.google.com›store›apps›sebiscores iOS: https://apps.apple.com›app›sebiscores.


Disclaimer: Investment in the securities market are subject to market risks, read all the related documents carefully before investing. Brokerage will not exceed the SEBI prescribed limit


Attention investors:

  1. Stock brokers can accept securities as margins from clients only by way of pledge in the depository system w.e.f September 01, 2020.
  2. Update your e-mail and phone number with your stock broker / depository participant and receive OTP directly from depository on your e-mail and/or mobile number to create pledge.
  3. Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month.

SEBI presents Samajh Se Investing Simple:

  • Understand Before You Invest
  • Choose Regulated Investment Products
  • Start Early, Stay Invested
  • Beware of Investment Frauds

Reporting of Short Sell Transactions by Clients:

Clients must report any short sale transaction, by emailing help@dhan.co with the subject “Reporting of Short Sell” on the same day.


Note: As a policy we do not give stock tips or recommendations and have not authorized anyone to give this on behalf of us. If you know anyone claiming to be a part of Dhan / / Raise or our associate companies or partners and offering such services, please report us on help@dhan.co. Important Information for Investors: To prevent unauthorized transactions in your trading / demat account, do not share your account details, credentials or any personal details with anyone. Keep your mobile number updated with your Stock Broker, Depository Participant and ensure that the same is registered with Stock Exchanges, Depository and KRAs. You will receive alerts and information on your registered mobile number / email for debit and other important transactions in your demat account directly from CDSL / Exchange on the same day. KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (Stock Broker, DP, Mutual Fund, etc.), you need not undergo the same process again when you approach another intermediary. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account. This is issued in the interest of investors.


Investors should be cautious on unsolicited emails and SMS advising to buy, sell or hold securities and trade only on the basis of informed decision. Investors are advised to invest after conducting appropriate analysis of respective companies and not to blindly follow unfounded rumours, tips etc. Further, you are also requested to share your knowledge or evidence of systemic wrongdoing, potential frauds or unethical behaviour through the anonymous portal facility provided on BSE & NSE website. Issued in the interest of the investors.


Raise Securities Private Limited also known as Dhan is only an order collection platform that collects orders on behalf of clients and places them on BSE StarMF for execution. Client expressly agrees that Dhan is not liable or responsible and does not represent or warrant any damages regarding non- execution of orders or any incorrect execution of orders with regard to the funds chosen by the client or due to, but not being limited to, any link/system failure, delay in transfer of the funds on account of any unforeseen circumstances/issues in the banking system/payment aggregators or any other problems that may result in a delay in crediting the funds into the BSE Star MF's bank account. Raise Securities Private Limited (Dhan) does not engage in proprietary trading on its own account.


Mutual fund investments are subject to market risks, read all scheme related documents carefully before investing. Dhan is not a distributor or agent of any mutual fund. Mutual Funds are not exchange-traded products. Any related disputes will not have access to the Exchange-investor redressal forum or arbitration mechanism. For other disclaimers please refer https://dhan.co/advertisement-disclaimer/


Download client registration documents (Rights & Obligations, Risk Disclosure Document, Do's & Don'ts) in vernacular language: BSE | NSE | MCX


Kindly, read the Advisory Guidelines of BSE | NSE | MCX for investors as prescribed by the exchange with reference to their circular dated 27th August, 2021 regarding investor awareness and safeguarding client's assets


Important Links: SEBI | BSE | NSE | MCX | CDSL | SCORES | ODR Portal | Investor Charter for Stock Brokers | Investor Charter for DP | Investor Charter for Research Analyst | UCC Advisory | e-Voting for Shareholders | NCL Client Collateral details | MCXCCL Client Collateral details

Important Information: Terms of Usage | Disclaimers | Privacy Policy | Grievances | Grievances RA | Risk Management Policy | Risk Disclosure | Advertisement Disclaimer | Referral Terms & Conditions | Saarthi 2.0 Mobile App for Investors | Master Circular for Online Dispute Resolution